Combined Analysis of Plasma Amphiregulin and Heregulin Predicts Response to Cetuximab in Metastatic Colorectal Cancer

• Kimio Yonesaka ,

  * E-mail: yonesaka@sakai.med.kindai.ac.jp

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Naoki Takegawa,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Taroh Satoh,

  Affiliation Department of Frontier Science for Cancer and Chemotherapy, Osaka University Graduate School of Medicine, Osaka, Japan

  ⨯
• Hiroto Ueda,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Takeshi Yoshida,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Masayuki Takeda,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Toshio Shimizu,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Yasutaka Chiba,

  Affiliation Clinical Research Center, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Isamu Okamoto,

  Affiliation Center for Clinical and Translational Research, Kyushu University, Fukuoka, Japan

  ⨯
• Kazuto Nishio,

  Affiliation Department of Genome Biology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Takao Tamura,

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯
• Kazuhiko Nakagawa

  Affiliation Department of Medical Oncology, Kinki University Faculty of Medicine, Osaka, Japan

  ⨯